Immunology & Immunotherapy Research
What is Immunology & Immunotherapy
Cancer immunology focuses on understanding interactions between cancer cells and the immune system, including how tumors evade or suppress anti-tumor immune responses. This knowledge aids development of immunotherapies that harness the immune system to fight cancer. Immunotherapy refers to treatments that boost the body’s natural defenses to combat cancer. Types of immunotherapies include immune checkpoint inhibitors, T-cell therapies, cancer vaccines, and adjuvant immunotherapies. These therapies help strengthen, direct, or restore the immune system’s ability to find and attack cancer cells.
NFCR IMPACTS IN IMMUNOLOGY & IMMUNOTHERAPY RESEARCH
- NFCR supports scientists to study tumor antigens and immune profiling to uncover new therapeutic targets and predict patient responses. This has expanded immunotherapy options for more cancer patients.
- NFCR supports translational research converting discoveries in cancer immunology into new treatments.
- NFCR’s grants have helped scientists to develop enhanced animal models for testing immunotherapies, improving preclinical evaluations and helping bring more treatments to human trials.
- NFCR provides funding for research into overcoming immunotherapy resistance pathways, including combination immunotherapies against advanced cancers, working to make immunotherapies effective for more patients.
NFCR-Supported Researchers Working on Immunology & Immunotherapy
Aaron N. Hata, M.D., Ph.D.
Harvard Medical School and Massachusetts General Hospital
Aaron N. Hata, M.D., Ph.D.
Harvard Medical School and Massachusetts General Hospital
Aaron N. Hata, M.D., Ph.D.
Harvard Medical School and Massachusetts General Hospital
Aaron N. Hata, M.D., Ph.D.
Harvard Medical School and Massachusetts General Hospital
Aaron N. Hata, M.D., Ph.D.
Harvard Medical School and Massachusetts General Hospital
Aaron N. Hata, M.D., Ph.D.
Harvard Medical School and Massachusetts General Hospital
Aaron N. Hata, M.D., Ph.D.
Harvard Medical School and Massachusetts General Hospital
Related Content
All Things Cancer Episode #12: Can CAR-T Therapy Finally Conquer Solid Tumors?
[vc_template name=”A world without”]
All Things Cancer Episode #10: Harnessing the Immune System with Drew Pardoll
[vc_template name=”A world without”]
All Things Cancer Episode #4: Dr. James Allison on Immunotherapy
[vc_template name=”A world without”]
[vc_template name=”A world without”]
A world without cancer is possible. Help us turn lab breakthroughs into life-saving realities.
5.7 Million+
Donors who have fueled NFCR’s mission
$420 Million+
Invested in high-impact research & programs
36+ Labs & Hundreds of
Nobel Laureates & Key Scientists received NFCR funding, driving breakthrough research
